Skip to main content
Fig. 2 | Lipids in Health and Disease

Fig. 2

From: Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction

Fig. 2

Assessment of cardiac function. a Examples of M-mode echocardiography in sham-operated, MI, sham and MI treated with t-AUCB after 1 week of treatment, showing evidence of cardiac failure with chamber dilatation in MI mice. T-AUCB prevented the development of chamber dilatation in MI mice. Summary data are shown in b. b Fractional shortening (FS), a surrogate of systolic function, was calculated from left ventricule dimension as follows: FS = ((EDD-ESD)/EDD) × 100%. Data were expressed as mean ± SEM; EDD, end diastolic dimension; ESD, end systolic dimension; *P<0.05 vs. sham group; #P<0.05 vs. MI group. n = 5

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X